This was observed for disialylated species, GD3 and GD2 [53–55], and GD3 synthase (GD3S), the regulatory enzyme of GD3 and GD2 synthesis was studied for its potential to serve as a novel drug target in cancer [56]. This evidence concerns the gene ST8SIA1 and cancer.